Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: A cost-effectiveness analysis. Pharmacogenet Genom 2006;16:139-147

Tobias Gerhard, Amber L. Beitelshees, Julie A. Johnson

Research output: Contribution to journalLetter

Original languageEnglish (US)
Number of pages1
JournalPharmacogenetics and Genomics
Volume16
Issue number8
DOIs
StatePublished - Aug 1 2006

Fingerprint

Calmodulin-Binding Proteins
Population Genetics
Genetic Testing
Cost-Benefit Analysis
Case-Control Studies
Hypertension
adducin

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

@article{2546a640f7484c949ad8445f7ec6737f,
title = "Re: Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: A cost-effectiveness analysis. Pharmacogenet Genom 2006;16:139-147",
author = "Tobias Gerhard and Beitelshees, {Amber L.} and Johnson, {Julie A.}",
year = "2006",
month = "8",
day = "1",
doi = "10.1097/01.fpc.0000220568.75219.a9",
language = "English (US)",
volume = "16",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Re

T2 - Meckley LM, Veenstra DL. Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: A cost-effectiveness analysis. Pharmacogenet Genom 2006;16:139-147

AU - Gerhard, Tobias

AU - Beitelshees, Amber L.

AU - Johnson, Julie A.

PY - 2006/8/1

Y1 - 2006/8/1

UR - http://www.scopus.com/inward/record.url?scp=33746211648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746211648&partnerID=8YFLogxK

U2 - 10.1097/01.fpc.0000220568.75219.a9

DO - 10.1097/01.fpc.0000220568.75219.a9

M3 - Letter

C2 - 16847430

AN - SCOPUS:33746211648

VL - 16

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

SN - 1744-6872

IS - 8

ER -